Does Semaglutide Cause Muscle Loss?

Summary: Roughly a quarter to two-fifths of weight lost on semaglutide is lean mass, in line with any rapid weight loss. Protein, resistance training, and slow titration blunt the muscle component and often preserve strength even when scale lean mass drops.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: yes. About 25% to 39% of the weight people lose on semaglutide is non-fat tissue, and a meaningful share of that is skeletal muscle. The 68-week STEP-1 body composition substudy put the lean mass loss at 6.9 kg out of a 17.3 kg total weight loss, or roughly 40% ^[1]. That is real muscle leaving your body, and it is the same pattern you see with bariatric surgery, very low calorie diets, or any other intervention that drives fast weight loss.

The more useful question is whether that loss matters, and what to do about it. The answer there is more nuanced than the headlines suggest.

What STEP-1 actually showed

STEP-1 was the pivotal phase 3 trial for semaglutide 2.4 mg (Wegovy) for weight management. 1,961 adults with overweight or obesity randomized to weekly semaglutide or placebo for 68 weeks. Weight loss in the semaglutide arm was 14.9% of body weight vs 2.4% with placebo ^[1].

A DXA body composition substudy ran in 140 participants. Headline numbers:

Two things jump out. First, the absolute lean mass drop (6.9 kg, about 15 lb) is large. Second, the proportional picture is less alarming. Because so much fat left at the same time, the ratio of lean mass to total body mass actually improved with semaglutide. Participants ended up with a higher fat-free mass percentage than they started with ^[1]. They lost muscle in kilograms, and gained it in percentage of bodyweight.

This is the central tension in every semaglutide muscle loss conversation. Absolute lean mass goes down. Body composition, by ratio, gets better. Whichever number you lead with shapes the conclusion.

Is 40% lean mass loss unusually high?

No. It is on the higher end of normal for fast weight loss, but it is not unique to GLP-1 drugs.

A systematic review across six semaglutide trials with 1,541 adults found lean mass reductions ranging from 0% to 40% of total weight loss ^[2]. A meta-analysis of bariatric surgery patients showed 21% to 22% of total weight loss came from fat-free mass within one year post-surgery. Very low calorie diets typically produce 25% to 30% lean mass loss. Any intervention that drives a sustained calorie deficit pulls some lean mass off the body. The faster the loss, the higher the lean fraction tends to run.

Put differently: muscle loss is a feature of weight loss, not a feature of semaglutide specifically. What semaglutide does is make rapid weight loss possible for people who could not previously sustain a calorie deficit. The drug is doing the calorie restriction part for them, and the body composition consequences follow.

Mass vs strength: the disconnect that matters

Muscle mass and muscle function do not always move together. The Funai lab at Utah published a 2025 study in Cell Metabolism showing that mice on semaglutide lost about 6% of skeletal muscle mass but lost more strength than the mass change predicted, in some muscles. Other muscles held their strength even as size dropped. The takeaway: DXA may overstate the meaningful muscle problem in some cases and understate it in others.

Human data is more reassuring. A Chinese cohort study of 24 weeks of semaglutide saw a 1.4 kg skeletal muscle mass loss, but grip strength did not change. Calf circumference held steady. Patients lost mass without losing measured function. Whether that holds over longer treatment periods and in older patients is the open question.

The clinical concern is sarcopenia, which is the loss of muscle mass plus loss of strength and function. Sarcopenia is associated with falls, fractures, and earlier mortality. Pure mass loss without functional loss is mostly a cosmetic and metabolic story. Sarcopenia is a survival story. The two need to be teased apart, and most popular media coverage of "Ozempic muscle loss" smashes them together.

Who is at highest risk

Some patients should be more careful than others. Higher risk for clinically meaningful muscle loss on semaglutide:

• Adults over 65. Baseline sarcopenia rates rise sharply after 60. Layering a fast weight loss intervention on top of age-related muscle loss compounds the problem ^[4].
• Anyone with low baseline muscle mass. Sarcopenic obesity (high body fat with low muscle) is a particular trap; the scale weight looks high but there is not much muscle to spare.
• Long-standing type 2 diabetes. Diabetes is independently associated with lower muscle quality and accelerated muscle decline.
• History of yo-yo dieting or repeated weight cycling. Each cycle tends to drop more muscle than fat is regained as muscle.
• Sedentary patients with low protein intake. The default trajectory if nothing changes.
• Patients losing weight very fast. Semaglutide-driven weight loss exceeding 1.5 to 2 pounds per week is in the danger zone for excess lean mass loss.

How to preserve muscle on semaglutide

Five interventions have evidence behind them. Stack them.

1. Protein, 1.2 to 1.6 g per kg

The Institute of Medicine RDA of 0.8 g/kg is for healthy adults at energy balance. People in an active calorie deficit lose more muscle at that intake. The consensus among obesity medicine specialists is 1.2 to 1.6 g/kg of reference body weight per day during active weight loss, and toward the upper end of that range for adults over 65 ^[3].

For a 90 kg adult, that is 108 to 144 g of protein per day. Spread across three or four meals, roughly 30 to 40 g per sitting. The "30 g per meal" target lines up with the leucine threshold for maximal muscle protein synthesis in most adults.

Practical sources, per typical serving:

Hitting the target with semaglutide-suppressed appetite is the hard part. Many people genuinely cannot eat 30 g of solid protein in a sitting once nausea or early satiety kicks in. A whey or casein shake between meals fills the gap. Liquid protein clears the stomach faster than dense food and is often better tolerated when GI side effects are active.

2. Resistance training, 2 to 3 sessions per week

Resistance training is the single intervention with the strongest evidence for preserving muscle during calorie restriction. A meta-analysis of dietary weight loss trials found that adding resistance training neutralized most of the muscle mass loss that diet alone produced.

For semaglutide patients, the recommended starting point is two to three sessions per week, 30 to 45 minutes per session, hitting the major muscle groups (legs, back, chest, shoulders, arms, core). It does not need to be a barbell program. Bodyweight squats, push-ups, lunges, planks, resistance band rows, and dumbbell work all qualify. The variable that matters is progressive overload, the muscle has to be challenged enough to signal "we still need this tissue."

Cardio (elliptical, swimming, walking, jogging) is great for cardiovascular health and burns calories, but it does not preserve muscle the way resistance work does. Yoga and pilates build some strength but are typically below the threshold for true hypertrophy stimulus. Use them as a supplement, not a replacement.

3. Slow titration and slower weight loss

The faster you lose weight, the higher the lean mass fraction of that loss tends to run. Going from 0.25 mg to 2.4 mg semaglutide over 16 weeks (the standard Wegovy titration) is already paced for tolerance. Some prescribers extend it further if a patient's lean mass numbers are worrying, holding at a lower dose like 1.0 mg or 1.7 mg rather than pushing to maintenance 2.4 mg.

Weight loss of 1 to 2 pounds per week is the sweet spot for body composition. Faster than 2 pounds per week sustained over months is associated with higher muscle loss, more loose skin, and higher rebound weight gain rates after discontinuation.

4. Creatine monohydrate

Creatine is the most studied supplement in sports nutrition and one of the few with consistent evidence in older adults and in calorie-restricted populations. Standard dose is 3 to 5 g per day, taken whenever, no loading phase needed. It supports muscle force output and may slightly increase total lean mass through increased intramuscular water and improved training capacity. Creatine is not a magic muscle preserver, but it is cheap, low-risk for healthy kidneys, and stacks well with resistance training.

5. Adequate calories

This sounds counterintuitive on a weight loss drug, but eating too little accelerates muscle loss without making fat loss any faster past a point. A reasonable calorie deficit on semaglutide is 500 to 750 calories below maintenance, not the 1,200 calorie all-day deficits some patients drift into when appetite suppression hits hard. If you find you have only eaten 800 calories by 6 pm, that is a problem to solve, not a win to bank.

What about testosterone and male muscle?

A common concern in male patients is whether semaglutide lowers testosterone and accelerates muscle loss that way. The honest answer is that the data is limited and mixed. Several small studies have shown that weight loss in obese men actually raises testosterone, because adipose tissue is the main site of testosterone-to-estrogen conversion via aromatase. Less fat tends to mean more circulating testosterone, not less.

There is no consistent signal that semaglutide directly suppresses the HPG axis or lowers testosterone independent of the weight loss. Men who do strict resistance training and protein on semaglutide often end the year with better body composition, better metabolic markers, and stable or improved testosterone. Bodybuilders using semaglutide for fat loss cycles are a small but real population; their protocols emphasize 1.6 to 2.2 g/kg protein and aggressive resistance training to minimize muscle loss during the cut.

The future: muscle-sparing combinations

The next phase of GLP-1 research is targeted muscle preservation alongside the appetite suppression. The lead candidate is bimagrumab, an injected monoclonal antibody that blocks activin/myostatin signaling and is being developed by Eli Lilly. In the phase 2 BELIEVE study, 507 adults on semaglutide plus bimagrumab achieved 22.1% body weight reduction at 72 weeks, with 92.8% of that loss coming from fat (vs 71.8% for semaglutide alone) ^[5]. Muscle loss in the combination arm was 2.9% vs 7.4% for semaglutide alone. Patients on bimagrumab monotherapy actually gained 2.5% muscle mass.

If those results hold up in phase 3, the muscle loss concern with GLP-1 therapy may become a transitional problem, solved by adding a second injection. Until then, the answer is protein, resistance training, and patience.

Fat loss: the other side of the coin

Semaglutide does preferentially remove fat. Total fat mass drops more than lean mass in nearly every study. Visceral adipose tissue (the metabolically dangerous fat around the abdominal organs) drops disproportionately, which is the main reason cardiovascular and metabolic outcomes improve on the drug. Subcutaneous belly fat goes too; that is the "Ozempic face" and slimmer waist that get the cultural attention. Semaglutide does not burn fat in the active sense of beta-oxidation, the way exercise or stimulants do. It engineers a calorie deficit by suppressing appetite and slowing gastric emptying. Your body covers the deficit by burning stored fat (and some lean tissue). The mechanism is upstream of fat metabolism, not at the mitochondrion.

How much muscle do you lose on semaglutide?

STEP-1 showed about 6.9 kg of lean mass loss over 68 weeks on semaglutide 2.4 mg, roughly 40% of total weight lost. Not all of that is skeletal muscle; some is organ and connective tissue.

Does Ozempic eat away at your muscles?

No, not directly. Semaglutide does not have a direct catabolic effect on muscle. The muscle loss is a consequence of rapid weight loss and reduced protein intake from appetite suppression. Eat enough protein and train, and most of it is preventable.

How do I prevent muscle loss on semaglutide?

Three things: 1.2 to 1.6 g protein per kg per day, resistance training 2 to 3 times per week, and a slower rate of weight loss (1 to 2 pounds per week). Creatine and adequate calories help.

Does Wegovy cause more muscle loss than Ozempic?

They contain the same drug, semaglutide. Wegovy uses a higher dose (2.4 mg) and produces more total weight loss, which means more absolute lean mass loss in kilograms. The percentage breakdown is similar.

Do bodybuilders use Ozempic?

A small number use it for fat loss cycles or off-season weight management. They counteract muscle loss with very high protein (1.8 to 2.2 g/kg), heavy resistance training, and short courses rather than long-term use. It is off-label and not recommended for lean athletes.

Can I exercise while on semaglutide?

Yes, and you should. Resistance training is the most important intervention for preserving muscle. Cardio (walking, swimming, elliptical) is fine and supports cardiovascular health. Watch for low blood sugar if you also take insulin or sulfonylureas, and hydrate aggressively if GI side effects are active.

Does semaglutide lower testosterone in men?

There is no consistent evidence that it does. Weight loss in men with obesity typically raises testosterone because fat tissue converts testosterone to estrogen. Less fat, more circulating testosterone, on average.

Does semaglutide burn belly fat specifically?

It preferentially reduces visceral fat (the deep abdominal fat around organs), which is the metabolically meaningful kind. Subcutaneous belly fat also drops. It does not target belly fat by mechanism; the visceral reduction is a downstream effect of overall calorie deficit and improved insulin sensitivity.

Should I get a DXA scan before starting semaglutide?

If you are over 60, have a history of falls or low muscle mass, or are athletically focused, yes. A baseline DXA at the start and a follow-up at six months gives real data on whether your weight loss is healthy. For younger patients with normal function, scale weight plus a tape measure is usually adequate.

Is the muscle loss permanent?

Mostly recoverable. Once you stop semaglutide or reach a maintenance dose with stable weight, resistance training and protein can rebuild most of the lost muscle within 6 to 12 months. Older adults rebuild more slowly than younger ones.

The bottom line

Semaglutide causes lean mass loss. That is settled science. Whether that lean mass loss matters depends on three things: how much of it is actually skeletal muscle (vs organ and water), whether you lose function or just mass, and what you do to mitigate it. The patient who hits 1.4 g/kg protein, lifts twice a week, and loses weight at 1.5 pounds per week will end the year stronger and healthier than they started, even with a lower DXA lean mass number. The patient who eats 900 calories of mostly carbs, never lifts, and drops 30 pounds in three months is the one who ends up with measurable sarcopenia and a higher rebound risk.

The drug is a tool. The body composition outcome is yours.